NRC Health Payments to Acquire Businesses, Gross
NRC Health (NRC) reported Payments to Acquire Businesses, Gross of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2026-03-05
- NRC Health payments to acquire businesses, gross for the quarter ending 2025-12-31 was $0.00.
- NRC Health payments to acquire businesses, gross for the quarter ending 2024-12-31 was $0.00.
- NRC Health payments to acquire businesses, gross for the quarter ending 2021-12-31 was $0.00.
- NRC Health payments to acquire businesses, gross for the quarter ending 2021-09-30 was $0.00.
- NRC Health payments to acquire businesses, gross for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- NRC Health payments to acquire businesses, gross for fiscal 2024 was $4.83M.
- NRC Health payments to acquire businesses, gross for fiscal 2023 was $0.00.
- NRC Health payments to acquire businesses, gross for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.83M 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $4.83M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-05 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-17 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $3.00M 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $3.00M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $3.00M 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-06 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |